BEBT-908 (PI3Kα inhibitor 1) |
カタログ番号GC33145 |
BEBT-908 (PI3Kα 阻害剤 1) (PI3Kα 阻害剤 1) は、選択的な PI3Kα です。特許US/201200889999994A1から抽出された阻害剤、化合物243は、IC50<0.1777777888888956を有する;M、PI3K777777888888945。阻害剤 1 は、HDAC も阻害します (0.1 μM≤IC50≤1 μM)。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1235449-52-1
Sample solution is provided at 25 µL, 10mM.
BEBT-908 is a selective PI3Kα inhibitor extracted from patent US/20120088764A1, Compound 243, has an IC50<0.1 μM, PI3Kα inhibitor 1 also inhibits HDAC (0.1 μM≤IC50≤1 μM) .
[1]. Cai Xiong, et al. Deazapurines, thienopyrimidines and furopyrimidines as phosphoinositide 3-kinase inhibitors with a zinc binding moiety and their preparation and use in the treatment of diseases. From U.S. Pat. Appl. Publ. (2012), US 20120088764 A1 20120412.
Average Rating: 5
(Based on Reviews and 34 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *